Form 4 for XRN Chiron Real Estate Inc.
Accepted 2025-06-25 00:00:00 ET · period of report 2025-06-23 · accession 0001104659-25-062678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-25 | 2025-06-24+ | XRN | Decker Mark Okey Jr | CEO, Pres, Dir | P - Purchase | $6.52 | +160.0K | 133.4K | New | +$1.04M |
| D | 2025-06-25 | 2025-06-23 | XRN | Decker Mark Okey Jr | CEO, Pres, Dir | A - Grant | $0.00 | +158.7K | 158.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-24 | P | A | 100,000 | $6.53 | 100,000 | D | — | — | (F1) This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4. |
| 2 | Common | Common Stock | 2025-06-24 | P | A | 2,668 | $6.37 | 102,668 | D | — | — | (F2) This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points. |
| 3 | Common | Common Stock | 2025-06-25 | P | A | 18,503 | $6.54 | 160,000 | D | — | — | (F5) This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points. |
| 4 | Common | Common Stock | 2025-06-25 | P | A | 8,072 | $6.56 | 141,497 | D | — | — | (F4) This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points. |
| 5 | Common | Common Stock | 2025-06-25 | P | A | 30,757 | $6.47 | 133,425 | D | — | — | (F3) This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points. |
| 6 | Derivative | LTIP Unit (Right to Buy) | 2025-06-23 | A | A | 158,730 | $0.00 | 158,730 | D | — · — to — | 158,730 Common Stock | (F6) Represents units of limited partnership interests ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) in connection with the Reporting Person's appointment as President and Chief Executive Officer, effective June 23, 2025 (the "grant date"). All of the LTIP Units vest on the third anniversary of the grant date. (F7) As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. |